2Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA,Sampliner RE, Mecks EL, Beack MJ. The Natural history of community-aquired hepatitis C in united. N Engl J Med 1992; 327:1899-1905
3Chemin I, Zoulim F, Merle P. High incidence of hepatitis B in fections among chronic hepatitis cases of unknown aetiology. J Hepatol 2001;34:447-452
4Brown N, Tisdale J, Barrett AJ, Dunbar CE, Young NS.Hepatitis-Associated aplastic anemia. N Engl J Med 1997;336:1059
5Perrillo RP. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologyically mediated liver disease. Sastroenterology 2001;120:1009-1022
6Hoofnagle JH, Dusheiko GM, Schafer DE, Jenes EA, Micetich KC, Young RC, Costa J. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982;96:447-449
7Lok ASF, Liang RHS, Chiu EKW, Wong KL, Chan TK, Todd D. Re activation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100:182-188
8Yeo W, Chan PK, Chan HL, Mo FK, Johnson PJ. Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis. J Med Virol2001;65:473-477
9Paterlini P, Poussin K, Kew M, Franco D, Brechot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigan with hetocellular carcinoma. Hepatology 1995;21:313-321
10Paulotsky JM, Bestie A, Hezode C, Lonjon I, Darthuy F, Remire J, Dhumeauz D. Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays. J Virol Methods 2000;85:11-21
9Hwang TS, Han HS, Hong YC,et al. Prognostic value of combined analysis of cyclinD1 and estrogen receptor status in breast cancer patients [ J ]. Pathol Int,2003,53 ( 2 ) :74-80.
10Guo SS, Wu X, Shimoide AT, et al. Frequent overexpression of cyclin D1 in sporadicpancreatic endocrine tumours[ J ]. J Endocrinol, 2003,179( 1 ) :73-79.
